Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with high-altitude pulmonary oedema: a meta-analysis

Abstract

Background and objective: High-altitude pulmonary oedema (HAPE) is a non-cardiogenic hydrostatic oedema involving a genetic component. Considering the low incidence of HAPE, sample sizes in current reports are relatively limited. We aimed to assess the association between the angiotensin-converting enzyme (ACE) I/D polymorphism and HAPE via a meta-analysis of published and unpublished data.

Materials and methods: We searched PubMed, CBM, CNKI, and Cochrane Library Database before 20 November 2010. A random-effects model was applied (STATA) and study quality was assessed in duplicate.

Results: A total of five studies including 305 cases and 662 controls were meta-analysed. The summary odds ratio (OR) indicated that no significant differences in risk of developing HAPE were found between carriers of ACE D and I alleles (OR = 1.20; 95% confidence interval (CI), 0.98–1.48; p = 0.084). Lack of association persisted for genotypes under the recessive mode. However, genotype association under the dominant mode showed D allele carriers significantly conferred a 1.55-fold increased HAPE risk compared with II genotype carriers (95% CI, 1.15–2.08; p = 0.004). Funnel plot and Egger’s test suggested no evidence of publication bias.

Conclusions: Our results supported the notion that ACE D allele carriers were at significant increased risk of developing HAPE.

Keywords

Angiotensin-converting enzyme association high-altitude pulmonary oedema insertion/deletion polymorphism meta-analysis

Get full access to this article

View all access options for this article.

References

Basnyat

Murdoch

. High-altitude illness. Lancet 2003; 361: 1967–1974.

Mortimer

Patel

Peacock

. The genetic basis of high-altitude pulmonary oedema. Pharmacol Ther 2004; 101: 183–192.

MacInnis

Michael

Jim

. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol 2010; 11: 349–368.

Luobu

Weijun

Guozhang

. Analysis of association of polymorphisms of angiotensin converting enzyme gene and angiotensinogen gene with high altitude pulmonary edema. Zhongguo Xunhuan Zazhi 2000; 1: 31–33.

Hotta

Hanaoka

Droma

Katsuyama

Ota

Kobayashi

. Polymorphisms of renin–angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 2004; 126: 825–830.

Niu

Zhu

Zhou

Qiu

. Synergistic effect of the genetic polymorphisms of the renin–angiotensin–aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 2008; 23: 143–152.

Charu

Stobdan

Ram

. Susceptibility to high altitude pulmonary oedema: role of ACE and ET-1 polymorphisms. Thorax 2006; 61: 1011–1012.

Niu

Zhu

. Genetic interaction of Hsp70 family genes polymorphisms with high-altitude pulmonary edema among Chinese railway constructors at altitudes exceeding 4000 meters. Clin Chim Acta 2009; 405: 17–22.

Droma

Hanaoka

Ota

. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002; 106: 826–830.

10.

Ahsan

Mohd

Norboo

Baig

Pasha

. Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest 2006; 130: 1511–1519.

11.

Hanaoka

Droma

Hotta

. Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest 2003; 123: 54–58.

12.

Hanaoka

Droma

Ota

Ito

Katsuyama

Kubo

. Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. Respirology 2009; 14: 46–52.

13.

Morrell

Morris

Stenmark

. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995; 269: H1186–H1194.

14.

Cargill

Lipworth

. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest 1996; 109: 424–429.

15.

Rigat

Hubert

Alhenc-Gelas

Cambien

Corvol

Soubrier

. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–1346.

16.

Pasha

Khan

Kumar

. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 2002; 27: 67–70.

17.

Montgomery

Marshall

Hemingway

. Human gene for physical performance. Nature 1998; 393: 221–222.

18.

Qadar Pasha

Khan

Kumar

. Angiotensin-converting enzyme insertion allele in relation to high altitude adaptation. Ann Hum Genet 2001; 65: 531–536.

19.

Dehnert

Weymann

Montgomery

. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 2002; 34:1928–1933.

20.

Kumar

Pasha

Khan

Gupta

. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat Space Environ Med 2004; 75: 981–983.

21.

Tiret

Rigat

Visvikis

. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197–205.

22.

Lau

Ioannidis

Schmid

. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820–826.

23.

Higgins

Thompson

Deeks

Altman

. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557–560.

24.

Walker

Hernandez

Kattan

. Meta-analysis: Its strengths and limitations. Cleve Clin J Med 2008; 75: 431–439.

25.

Saxena

Kumar

Madan

Gupta

Muralidhar

Sarma

. Association of polymorphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema. Chest 2005; 128: 1611–1619.

26.

Schoene

. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol 2004; 5: 125–135.

27.

Lunetta

. Genetic association studies. Circulation 2008; 118: 96–101.